• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制性抗体 3D11 对环子孢子蛋白重复序列的结构定序。

Structural ordering of the circumsporozoite protein repeats by inhibitory antibody 3D11.

机构信息

Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.

Department of Biochemistry, University of Toronto, Toronto, Canada.

出版信息

Elife. 2020 Nov 30;9:e59018. doi: 10.7554/eLife.59018.

DOI:10.7554/eLife.59018
PMID:33253113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7704109/
Abstract

Plasmodium sporozoites express circumsporozoite protein (CSP) on their surface, an essential protein that contains central repeating motifs. Antibodies targeting this region can neutralize infection, and the partial efficacy of RTS,S/AS01 - the leading malaria vaccine against (Pf) - has been associated with the humoral response against the repeats. Although structural details of antibody recognition of PfCSP have recently emerged, the molecular basis of antibody-mediated inhibition of other Plasmodium species via CSP binding remains unclear. Here, we analyze the structure and molecular interactions of potent monoclonal antibody (mAb) 3D11 binding to CSP (PbCSP) using molecular dynamics simulations, X-ray crystallography, and cryoEM. We reveal that mAb 3D11 can accommodate all subtle variances of the PbCSP repeating motifs, and, upon binding, induces structural ordering of PbCSP through homotypic interactions. Together, our findings uncover common mechanisms of antibody evolution in mammals against the CSP repeats of Plasmodium sporozoites.

摘要

疟原虫孢子表面表达环子孢子蛋白(CSP),这是一种含有中心重复基序的必需蛋白。针对该区域的抗体可以中和感染,RTS,S/AS01——针对(Pf)的领先疟疾疫苗——的部分功效与针对重复序列的体液反应有关。尽管最近出现了抗体识别 PfCSP 的结构细节,但通过 CSP 结合介导其他疟原虫物种的抗体抑制的分子基础仍不清楚。在这里,我们使用分子动力学模拟、X 射线晶体学和 cryoEM 分析了强效单克隆抗体(mAb)3D11 与 PbCSP(PbCSP)结合的结构和分子相互作用。我们揭示了 mAb 3D11 可以容纳 PbCSP 重复基序的所有细微变化,并且在结合后通过同源相互作用诱导 PbCSP 的结构有序化。总之,我们的研究结果揭示了针对疟原虫孢子 CSP 重复序列的哺乳动物抗体进化的共同机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/dc6ed7d209cf/elife-59018-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/bb24b511cdca/elife-59018-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/0bdfb2d9080a/elife-59018-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/84bf19fdf43b/elife-59018-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/6e040c08b0ad/elife-59018-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/28e53547d599/elife-59018-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/c366c6208aeb/elife-59018-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/8addf53b4b9c/elife-59018-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/d187a3124d5d/elife-59018-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/bf12822497a8/elife-59018-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/218f1107396d/elife-59018-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/aa0e016d16df/elife-59018-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/74cb23a350e7/elife-59018-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/79fe1b6860fa/elife-59018-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/459f659f14dd/elife-59018-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/dc6ed7d209cf/elife-59018-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/bb24b511cdca/elife-59018-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/0bdfb2d9080a/elife-59018-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/84bf19fdf43b/elife-59018-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/6e040c08b0ad/elife-59018-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/28e53547d599/elife-59018-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/c366c6208aeb/elife-59018-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/8addf53b4b9c/elife-59018-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/d187a3124d5d/elife-59018-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/bf12822497a8/elife-59018-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/218f1107396d/elife-59018-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/aa0e016d16df/elife-59018-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/74cb23a350e7/elife-59018-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/79fe1b6860fa/elife-59018-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/459f659f14dd/elife-59018-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6127/7704109/dc6ed7d209cf/elife-59018-fig5-figsupp3.jpg

相似文献

1
Structural ordering of the circumsporozoite protein repeats by inhibitory antibody 3D11.抑制性抗体 3D11 对环子孢子蛋白重复序列的结构定序。
Elife. 2020 Nov 30;9:e59018. doi: 10.7554/eLife.59018.
2
Structural basis of inhibition by antibodies binding to the circumsporozoite protein repeats.抗体结合到环子孢子蛋白重复序列的抑制作用的结构基础。
Elife. 2022 Jan 13;11:e72908. doi: 10.7554/eLife.72908.
3
Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei.抗环子孢子蛋白单克隆抗体对转基因伯氏疟原虫的功能抗体介导抑制作用的比较分析。
Malar J. 2023 Nov 7;22(1):335. doi: 10.1186/s12936-023-04765-2.
4
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire.高亲和力结合疟原虫环子孢子蛋白重复序列由人免疫球蛋白库在小鼠中诱导的抑制性抗体产生。
PLoS Pathog. 2022 Nov 28;18(11):e1010999. doi: 10.1371/journal.ppat.1010999. eCollection 2022 Nov.
5
Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.纳米颗粒疫苗诱导的针对恶性疟原虫环子孢子蛋白的保护性抗体和CD8+ T细胞反应。
PLoS One. 2012;7(10):e48304. doi: 10.1371/journal.pone.0048304. Epub 2012 Oct 29.
6
Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.由恶性疟原虫环子孢子蛋白为基础的自组装蛋白纳米颗粒疫苗诱导的保护性免疫应答的机制。
Malar J. 2013 Apr 22;12:136. doi: 10.1186/1475-2875-12-136.
7
A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.一种基于单克隆抗体的免疫测定法,用于检测针对恶性疟原虫环子孢子蛋白重复区域的抗体反应。
Malar J. 2016 Nov 8;15(1):543. doi: 10.1186/s12936-016-1596-8.
8
Importance of the Immunodominant CD8 T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.伯氏疟原虫环子孢子蛋白免疫显性 CD8 T 细胞表位在寄生虫和疫苗诱导保护中的重要性。
Infect Immun. 2020 Sep 18;88(10). doi: 10.1128/IAI.00383-20.
9
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.自然接触寄生虫可诱导人体产生保护性抗疟抗体。
Immunity. 2017 Dec 19;47(6):1197-1209.e10. doi: 10.1016/j.immuni.2017.11.007. Epub 2017 Nov 29.
10
Generation of a Genetically Modified Chimeric Parasite Expressing Circumsporozoite Protein for Malaria Vaccine Development.用于疟疾疫苗开发的表达环子孢子蛋白的基因修饰嵌合寄生虫的产生。
Front Cell Infect Microbiol. 2020 Dec 17;10:591046. doi: 10.3389/fcimb.2020.591046. eCollection 2020.

引用本文的文献

1
Late killing of sporozoites in the liver by an anti-circumsporozoite protein antibody.抗环子孢子蛋白抗体对肝脏中疟原虫子孢子的晚期杀伤作用。
Elife. 2025 Feb 14;14:RP105291. doi: 10.7554/eLife.105291.
2
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
3
Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.

本文引用的文献

1
3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM.3D 变异性分析:从单颗粒冷冻电镜中解析连续的柔韧性和离散的异质性。
J Struct Biol. 2021 Jun;213(2):107702. doi: 10.1016/j.jsb.2021.107702. Epub 2021 Feb 11.
2
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.抗疟原虫环子孢子蛋白重复基序的保护性人抗体的进化。
Nat Med. 2020 Jul;26(7):1135-1145. doi: 10.1038/s41591-020-0881-9. Epub 2020 May 25.
3
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab.
探索恶性疟原虫环子孢子蛋白上的新型表位以用于疫苗开发。
NPJ Vaccines. 2024 Nov 18;9(1):225. doi: 10.1038/s41541-024-01006-8.
4
Malaria vaccines: a new era of prevention and control.疟疾疫苗:预防和控制的新时代。
Nat Rev Microbiol. 2024 Dec;22(12):756-772. doi: 10.1038/s41579-024-01065-7. Epub 2024 Jul 18.
5
A candidate antibody drug for prevention of malaria.一种预防疟疾的候选抗体药物。
Nat Med. 2024 Jan;30(1):117-129. doi: 10.1038/s41591-023-02659-z. Epub 2024 Jan 2.
6
Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N-terminal domain.疟原虫环子孢子蛋白 N 端结构域的生物物理特性分析。
Protein Sci. 2024 Jan;33(1):e4852. doi: 10.1002/pro.4852.
7
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein.针对恶性疟原虫环子孢子蛋白的 VH3-33 抗体的交叉反应性和效力的分子决定因素。
Cell Rep. 2023 Nov 28;42(11):113330. doi: 10.1016/j.celrep.2023.113330. Epub 2023 Oct 28.
8
Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei.抗环子孢子蛋白单克隆抗体对转基因伯氏疟原虫的功能抗体介导抑制作用的比较分析。
Malar J. 2023 Nov 7;22(1):335. doi: 10.1186/s12936-023-04765-2.
9
Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection.亲和力成熟的同源相互作用诱导 PfCSP 结构谱,影响对疟疾感染的保护。
Nat Commun. 2023 Jul 28;14(1):4546. doi: 10.1038/s41467-023-40151-x.
10
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire.高亲和力结合疟原虫环子孢子蛋白重复序列由人免疫球蛋白库在小鼠中诱导的抑制性抗体产生。
PLoS Pathog. 2022 Nov 28;18(11):e1010999. doi: 10.1371/journal.ppat.1010999. eCollection 2022 Nov.
CD20 结构与其治疗性单克隆抗体利妥昔单抗复合物。
Science. 2020 Mar 13;367(6483):1224-1230. doi: 10.1126/science.aaz9356. Epub 2020 Feb 20.
4
Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein.疟原虫环子孢子蛋白保守结构基序的多样化抗体反应。
J Mol Biol. 2020 Feb 14;432(4):1048-1063. doi: 10.1016/j.jmb.2019.12.029. Epub 2019 Dec 27.
5
Antibodies against Plasmodium falciparum malaria at the molecular level.针对疟原虫的抗体在分子水平上。
Nat Rev Immunol. 2019 Dec;19(12):761-775. doi: 10.1038/s41577-019-0209-5. Epub 2019 Aug 28.
6
Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.阐明耐药性疟原虫的作用机制。
Cell Host Microbe. 2019 Jul 10;26(1):35-47. doi: 10.1016/j.chom.2019.06.001.
7
Functional Comparison of Blood-Stage Malaria Vaccine Candidate Antigens.血期疟疾疫苗候选抗原的功能比较。
Front Immunol. 2019 Jun 4;10:1254. doi: 10.3389/fimmu.2019.01254. eCollection 2019.
8
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.抗体针对不同环子孢子蛋白表位的浓度和亲和力与 RTS,S/AS01E 疟疾疫苗的功效相关。
Nat Commun. 2019 May 15;10(1):2174. doi: 10.1038/s41467-019-10195-z.
9
RTS,S malaria vaccine pilots in three African countries.在三个非洲国家开展的RTS,S疟疾疫苗试点项目。
Lancet. 2019 Apr 27;393(10182):1685. doi: 10.1016/S0140-6736(19)30937-7.
10
Development of B Cell Memory in Malaria.疟疾中 B 细胞记忆的发展。
Front Immunol. 2019 Apr 2;10:559. doi: 10.3389/fimmu.2019.00559. eCollection 2019.